Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women

Archive ouverte

Corsini, Carole | Henouda, Sarra | Nejima, Dalel Ben | Bertet, Héléna | Toledano, Alain | Boussen, Hamouda | Habib, Faouzi | Mouhout, Asma | Gaballah, Ahmed | Ghazaly, Hesham El | Bourgier, Céline | Coupier, Isabelle | Galibert, Virginie | Baudry, Karen | Vilquin, Paul | Biquard, Louise | Rey, Jean-Marc | Belkacemi, Yazid | Ihout, Paul | Khayat, David | Picot, Marie-Christine | Bensalem, Assia | Pujol, Pascal

Edité par CCSD -

International audience. PURPOSE: This report compares the risk factors, the tumor phenotypes, and the BRCA1/BRCA2 genotype of early onset breast cancer (EOBC) patients between Southern Europe and North Africa. METHODS: Four hundred and fifty six women with invasive EOBC (<=40~years) were prospectively included from four centers in France (n~=~270) and four centers in North Africa (Algeria, Egypt, Morocco, Tunisia; n~=~186). Life style, tumor phenotype, familial history, BRCA1/BRCA2 genotype were compared between the two populations. RESULTS: We found an older age at menarche, a higher number of childbearing, a more frequent breastfeeding, a higher body mass index, a lower use of oral contraceptives in North African women compared to French women. TNM stage at diagnosis was higher in North African women than in French women. North African women had a lower incidence of triple negative and proliferative (Ki 67 index~\textgreater~20%) tumors. There was a lower rate of BRCA1 mutation in North Africa (7 vs. 15%, P~=~0.02). Three putative BRCA1/2 founder mutations were identified in North Africa. CONCLUSIONS: In EOBC, we found~significant differences in risk factors, phenotype and a higher incidence of BRCA1 mutations in Southern Europe as compared to North Africa. The worst prognosis previously reported for EOBC in North Africa is more likely due to a higher stage at diagnosis than to a more aggressive phenotype, since triple negative tumors are more common in Southern Europe and advanced tumors in North Africa.

Consulter en ligne

Suggestions

Du même auteur

Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

Archive ouverte | Pujol, Pascal | CCSD

IF 3.636 (2017). International audience. In oncology, the expanding use of multi-gene panels to explore familial cancer predisposition and tumor genome analysis has led to increased secondary findings discoveries (S...

Role of the general practitioner in the care of BRCA1 and BRCA2 mutation carriers: General practitioner and patient perspectives

Archive ouverte | Vande Perre, Pierre | CCSD

International audience. BACKGROUND: General practitioners (GPs) have an increasing role in referring patients with putative mutation in BRCA1/2 genes for genetics consultation and for long-term follow-up of mutation...

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families

Archive ouverte | Imbert-Bouteille, Marion | CCSD

International audience. According to clinical guidelines, the occurrence of very early-onset breast cancer (VEO-BC) (diagnosed ≤ age 30 years) or VEO ovarian cancer (VEO-OC) (diagnosed ≤ age 40 years) in families wi...

Chargement des enrichissements...